ION337

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION337, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome [Phase 1, Phase 2]